Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Mech Ageing Dev ; 207: 111713, 2022 10.
Article in English | MEDLINE | ID: mdl-35931241

ABSTRACT

Inflammaging is a low-grade inflammatory state generated by the aging process that can contribute to frailty and age-related diseases in the elderly. However, it can have distinct effects in the elderly living in endemic areas for infectious diseases. An increased inflammatory response may confer protection against infectious agents in these areas, although this advantage can cause accelerating epigenetic aging. In this study, we evaluated the inflammatory profile and the epigenetic age of infected and noninfected individuals from an endemic area in Brazil. The profile of cytokines, chemokines and growth factors analyzed in the sera of the two groups of individuals showed similarities, although infected individuals had a higher concentration of these mediators. A significant increase in IL-1ra, CXCL8, CCL2, CCL3 and CCL4 production was associated with leprosy infection. Notably, elderly individuals displayed distinct immune responses associated with their infection status when compared to adults suggesting an adaptive remodelling of their immune responses. Epigenetic analysis also showed that there was no difference in epigenetic age between the two groups of individuals. However, individuals from the endemic area had a significant accelerated aging when compared to individuals from São Paulo, a non-endemic area in Brazil. Moreover, the latter cohort was also epigenetically aged in relation to an Italian cohort. Our data shows that living in endemic areas for chronic infectious diseases results in remodelling of inflammaging and acceleration of epigenetic aging in individuals regardless of their infectious status. It also highlights that geographical, genetic and environmental factors influence aging and immunosenescence in their pace and profile.


Subject(s)
Communicable Diseases , Interleukin 1 Receptor Antagonist Protein , Aged , Aging/genetics , Brazil/epidemiology , Chemokines , Cytokines , Epigenesis, Genetic , Humans
2.
Benef Microbes ; 9(3): 477-486, 2018 Apr 25.
Article in English | MEDLINE | ID: mdl-29633632

ABSTRACT

The use of probiotics to prevent or treat mucosal inflammation has been studied; however, the combined effect of probiotics and prebiotics is unclear. The aim of this study was to test whether oral administration of a synbiotic (Simbioflora®) preparation containing Lactobacillus paracasei, Lactobacillus rhamnosus, Lactobacillus acidophilus and Bifidobacterium lactis plus fructooligosaccharide could help control mucosal inflammation in experimental mucositis induced by 5-fluorouracil (5-FU). Male BALB/c mice were randomly divided into six groups: control (CTL), control + prebiotic (CTL+P), control + synbiotic (CTL+S), mucositis (MUC), mucositis + prebiotic (MUC+P), and mucositis + synbiotic (MUC+S). Mice from the CTL+S, MUC+S, CTL+P, and MUC+P groups received synbiotic or prebiotic daily by oral gavage for 13 days. Mice in the CTL and MUC groups received the same volume of saline. On day 11, mice in the MUC, MUC+P, and MUC+S groups received an intraperitoneal injection of 300 mg/kg 5-FU to induce mucositis. After 72 h, all mice were euthanised. Intestinal permeability, intestinal histology, and biochemical parameters were analysed. Group MUC showed a greater weight loss and increased intestinal permeability (0.020 counts per min [cpm]/g) compared to the CTL group (0.01 cpm/g) P<0.05. Both treatments attenuated weight loss compared to the MUC group. Nonetheless, the synbiotic caused a greater reduction in intestinal permeability (0.012 cpm/g) compared to the MUC (0.020 cpm/g) and MUC+P (0.016 cpm/g) groups P<0.05. Mice in groups MUC+P and MUC+S displayed significant recovery of lesions and maintenance of the mucus layer. There were no differences in the short-chain fatty acid concentrations in the faeces between the MUC and CTL groups (P>0.05). Increased acetate and propionate concentrations were evidenced in the faeces of the MUC+P and MUC+S groups. Only the synbiotic treatment increased the butyrate concentration (P<0.05). The results indicate that administration of synbiotic can decrease mucosal damage caused by mucositis.


Subject(s)
Mucositis/prevention & control , Synbiotics/administration & dosage , Administration, Oral , Animals , Bifidobacterium animalis/growth & development , Bifidobacterium animalis/metabolism , Body Weight , Fatty Acids, Volatile/analysis , Feces/chemistry , Fluorouracil/administration & dosage , Fluorouracil/toxicity , Gastrointestinal Tract/pathology , Lactobacillus/growth & development , Lactobacillus/metabolism , Mice, Inbred BALB C , Mucositis/chemically induced , Oligosaccharides/administration & dosage , Oligosaccharides/metabolism , Treatment Outcome
3.
Scand J Immunol ; 73(1): 36-45, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21129001

ABSTRACT

The spleen is a secondary lymphoid organ that harbours a variety of cells such as T and B lymphocytes and antigen-presenting cells important to immune response development. In this study, we evaluated the impact of spleen removal in the immune response to experimental Trypanosoma cruzi infection. C57BL/6 mice were infected with Y strain of the parasite and infection was followed daily. Mice that underwent splenectomy had fewer parasites in peripheral blood at the peak of infection; however, mortality was increased. Histological analysis of heart and liver tissues revealed an increased number of parasites and inflammatory infiltrates at these sites. Spleen removal was associated with reduction in IFN-γ and TNF-α production during infection as well as with a decrease in specific antibody secretion. Haematological disorders were also detected. Splenectomized mice exhibited severe anaemia and decreased bone marrow cell numbers. Our results indicate that spleen integrity is critical in T. cruzi infection for the immune response against the parasite, as well as for the control of bone marrow haematological function.


Subject(s)
Chagas Disease/immunology , Parasitemia/immunology , Spleen/immunology , Trypanosoma cruzi/immunology , Animals , Chagas Disease/mortality , Chagas Disease/parasitology , Cytokines/blood , Enzyme-Linked Immunosorbent Assay , Female , Heart/parasitology , Histocytochemistry , Interferon-gamma/blood , Liver/parasitology , Mice , Mice, Inbred C57BL , Parasitemia/mortality , Parasitemia/parasitology , Spleen/parasitology , Spleen/surgery , Splenectomy , Tumor Necrosis Factor-alpha/blood
4.
Cell Immunol ; 249(1): 1-7, 2007 Sep.
Article in English | MEDLINE | ID: mdl-18093575

ABSTRACT

Spleen is one of the largest lymphoid organs in the body; it harbors immune cells including antigen presenting cells, B and T lymphocytes. It has an important role in humoral and cellular immune responses. Herein we investigated the role of spleen in the immune response to experimental Leishmania major infection. It is known that C57BL/6 mice are resistant to L. major infection whereas BALB/c mice are susceptible. Although splenectomy was associated with reduced serum levels of IFN-gamma, absence of the spleen did not change the profile of L. major infection in the resistant C57BL/6 and BALB/c susceptible mice. Both strains of mice maintained the same profile of cytokine production in regional lymph nodes after splenectomy and responded in the same way against the infection. Only splenectomized BALB/c mice had a reduction in IL-4 and IL-10 production by lymph node cells early in infection. Our data suggest that, in localized infections, regional lymph nodes may replace efficiently the immunological role of spleen in the cellular and humoral immune responses.


Subject(s)
Leishmania major , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/surgery , Splenectomy , Animals , Cells, Cultured , Cytokines/biosynthesis , Hindlimb , Interferon-gamma/biosynthesis , Interferon-gamma/blood , Interleukin-10/biosynthesis , Interleukin-4/biosynthesis , Leishmaniasis, Cutaneous/metabolism , Lymph Nodes/immunology , Lymph Nodes/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Skin/parasitology , Skin/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...